U.S. FDA approves 1st new Alzheimer’s drug in nearly 20 years

American government health officials have approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.

• ‘People are desperate’: New Alzheimer’s drug met with hope, skepticism
• Third FDA panel member quits over Alzheimer’s drug approval
• Controversial Alzheimer’s drug approved in U.S. Where does Canada stand?